In gastric cancer cells, this inhibitor has demonstrated the ability to block endogenous TRPC6 channels, leading to cell cycle arrest in the G2/M phase and inhibiting cell growth (Cai et al., 2009). The gene discussed is TRPC6; the disease is gastric cancer.